Öztürk Ateş, Gulsah Nomak, Hakan Sedat Orer, Recep Selim Şentürk, Fevzi Altuntas, Hamdi Sena Nomak, Rana Sanyal. "Phase 1a dose-escalation study of RS-0139: A novel tumor-targeted nanomedicine for advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15006